COMP <GO>
THC vs UHS // RSI-14 & 200D SMA MOMENTUM
Tenet Healthcare Corporation (NYSE) VS. Universal Health Services Inc. (NYSE) • 15-METRIC TALLY: THC 6
— UHS 7
▲ RSI-14 & 200D SMA MOMENTUM LEADER: THC
LAST: $268.89 (-1.60%) • MKT CAP: $21.75B
rsi-technicals
57.6
LAST: $180.65 (+2.61%) • MKT CAP: $10.38B
rsi-technicals
45.7
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (THC VS. UHS)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | THC | UHS | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 27.60% | 14.10% | +13.50 | THC | /roic <GO> |
| EV/EBITDA & P/E Valuation | 6.3x | 5.0x | +1.30 | UHS | /valuation <GO> |
| Free Cash Flow Yield | 11.61% | 8.16% | +3.45 | THC | /fcf-yield <GO> |
| Operating Margin | 16.50% | 11.50% | +5.00 | THC | /operating-margins <GO> |
| Net Profit Margin | 11.10% | 8.60% | +2.50 | THC | /net-margins <GO> |
| Revenue Growth (YoY) | 3.10% | 9.70% | -6.60 | UHS | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.49% | -0.49 | UHS | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.08 | 3.11 | -1.03 | UHS | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 9/9 | -3.00 | UHS | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 57.6 | 45.7 | +11.90 | THC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.97 | 1.04 | -0.07 | UHS | /macro-sensitivity <GO> |
| Forward P/E Multiple | 8.6x | 6.5x | +2.10 | UHS | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $21.75B | $10.38B | $11.37B | THC | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | THC REV | UHS REV | THC GROSS % | UHS GROSS % | THC FCF | UHS FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $21.31B | $17.36B | — | — | $2.53B | $849.2M |
| FY 2024 | $20.68B | $15.83B | — | — | $1.12B | $1.12B |
| FY 2023 | $20.56B | $14.28B | — | — | $1.45B | $625.1M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
THC // BETA 0.97
UHS // BETA 1.04